Tag: acesion


Acesion announces positive phase two data from AF clinical trial

Acesion, the biotech developing first-in-class novel therapies for atrial fibrillation (AF), has today announced positive data from its phase two trial of AP30663, a...

Acesion Pharma receives approval for Phase I study in atrial fibrillation

Acesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, announced it has received approval to...